Lionheart Capital

Lionheart Health is a biotechnology and medical technology company focused on regenerative medicine and longevity. Founded by serial inventor Howard Leonhardt and backed by Leonhardt Ventures, the company utilizes a proprietary bioelectric stimulation platform to control the expression of specific regenerative proteins and home stem cells to damaged tissues. Its extensive pipeline includes over 30 programs targeting heart failure, hair restoration, skin rejuvenation, joint health, and various organ-specific regeneration therapies. Lionheart Health aims to commercialize these technologies through a network of branded medspas and clinical partnerships, leveraging decades of research into bioelectric protein signaling to reverse aging and treat chronic diseases.